Loading…
MeiraGTx is a clinical stage genetic medicine company developing therapies for both rare and prevalent diseases. It focuses on precision control of gene expression through its riboswitch gene regulation platform and end-to-end manufacturing ecosystem.
AI named MeiraGTx in December 2025.